Thursday, June 22, 2017 1:47:34 PM
Its sort of mind-blowing the total lack of interest with the market cap so low.
VBIO is trading at 5x the market cap? I was certain it had started to come crashing down, but it has somehow stairstepped back up all of its losses. I can't find any information about timeline of when they would actually start clinical trials. Definitely not in 2017, and cant find any information about early 2018. Nor is there any data about drugs they are formulating, or animal-model results.
Anybody have any links to ANY of this information on VBIO that would be critical to a drug company? Or do drug companies not need this anymore, they just need to put money in PR campaigns.
Recent SKYE News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM